The ethics of research without consent in emergency situations

Mount Sinai Journal of Medicine

Volumn 72, Issue 4, 2005, Pages 242-249

  Richardson, Lynne D ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Community consultation; Emergency medicine; Emergency research; Exception to informed consent; Human experimentation; Informed consent; Public access defibrillation; Research ethics; Resuscitation research; Waiver of informed consent

Indexed keywords

ARTICLE; BENEFICENCE; CLINICAL PRACTICE; EMERGENCY HEALTH SERVICE; GOVERNMENT; HUMAN; INDEPENDENCE; INFORMATION PROCESSING; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; MEDICAL RESEARCH; METHODOLOGY; PATIENT ATTITUDE; PATIENT CARE; PATIENT PARTICIPATION; RESEARCH ETHICS; RISK ASSESSMENT; SAFETY;

BENEFICENCE; EMERGENCY MEDICINE; EMERGENCY SERVICE, HOSPITAL; FEDERAL GOVERNMENT; GOVERNMENT REGULATION; HUMANS; INFORMED CONSENT; MORAL OBLIGATIONS; PERSONAL AUTONOMY; PRACTICE GUIDELINES; RESUSCITATION; RISK ASSESSMENT; SOCIAL JUSTICE; THERAPEUTIC HUMAN EXPERIMENTATION; UNITED STATES;

EID: 22944491810     PISSN: 00272507     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Annas GJ, Gordin MA, editors. The Nazi doctors and the Nuremberg Code: Human rights in human experimentation. New York: Oxford University Press, 1992.
2. Bernard C. Vivisection. In: Reiser SJ, Dyck AJ, Curran WJ, editors. Ethics in medicine. Historical perspectives and contemporary concerns. Cambridge (MA): MIT Press; 1977. p. 257.
3. Gamble VN. Under the shadow of Tuskegee: African Americans and health care. Am J Public Health 1997; 87(1): 1773-1778.
4. U.S. Department of Health, Education and Welfare. Final Report on the Tuskegee Syphilis Study Ad Hoc Advisory Panel. Washington (DC): U.S. Government Printing Office; 1973.
5. Jones J. Bad blood: The Tuskegee syphilis experiment. New York: Free Press; 1993.
6. Faden R, editor. Human radiation experiments: final report of the president's advisory committee. New York: Oxford University Press; 1996.
7. Tribunals of War Criminals before the Nuremberg Military Tribunals under Central Council Law No. 10, Volume II. Washington (DC): U.S. Government Printing Office; 1949.
8. World Medical Organization. Declaration of Helsinki. Finland. 1964. BMJ 1996; 313(7070):1448-1449.
9. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. Washington (DC): Office for Protection from Research; 1979. http://ohsr.od.nih.gov (Regulations and Ethical Guidelines section) (accessed 1/19/05).
10. U.S. Department of Health and Human Services. Code of Federal Regulations, Title 45, Part 46 (102i): Protection of Human Subjects (HHS), 1991.
11. U.S. Food and Drug Administration. Code of Federal Regulations, Title 21, Part 50. Protection of Human Subjects (Informed Consent Regulations FDA), 1991.
12. Borak J, Veilleux S. Informed consent in emergency settings. Ann Emerg Med 1984; 13(9 Pt 1):731-735.
13. Boisaubin EV, Dresser R. Informed consent in emergency care: illusion and reform. Ann Emerg Med 1987; 16:62-67.
14. Spivey WH. Informed consent for clinical research in the emergency department. Ann Emerg Med 1989; 18:766-771.
15. Kim DT, Spivey WH. A retrospective analysis of institutional review board and informed consent practices in EMS research. Ann Emerg Med 1994; 23:70-74.
16. Whitley TW, Spivey WH, Abramson NS, et al. A basic resource guide for emergency medicine research. Ann Emerg Med 1990; 9:1306-1309.
17. Yarborough M. What good are we doing? The role of clinical research in enhancing critical care medicine. J Crit Care 1993; 8(4):228-236.
18. Iserson KV, Mahowald MB. Acute care research: is it ethical? Crit Care Med 1992; 20(7):1032-1037.
19. Spivey WH, Abramson NS, Iserson KV, et al. Informed consent for biomedical research in acute care medicine. Ann Emerg Med 1991; 20: 1251-1265.
20. Abramson NS, Meisel A, Safar P. Deferred consent: a new approach for resuscitation research on comatose patients. JAMA 1986; 255:2466-2471.
21. Prentice ED, Antonson DL, Leibrock LG, et al. An update on the PEG-SOD study involving incompetent subjects: FDA permits an exception to informed consent requirements. IRB 1994; 16(1-2):16-18.
22. Abramson NS. Deferred consent: use in clinical resuscitation research. Ann Emerg Med 1990; 19:781-784.
23. Miller BL. Philosophical, ethical, and legal aspects of resuscitation medicine, I: deferred consent and justification of resuscitation research. Crit Care Med 1988; 16(10):1059-1062.
24. Biros MH, Runge JW, Lewis RJ, Doherty C. Emergency medicine and the development of the Food and Drug Administration's final rule on informed consent and waiver of informed consent in emergency research circumstances. Acad Emerg Med 1998; 5(4):359-368.
25. Ellis GB. 'Dear Colleague' letter: human subjects protection. OPRR Report. Aug 12, 1993; No. 93-3.
26. Advisory Committee on Human Radiation Experiments, Research Ethics and the Medical Profession. JAMA 1996; 276:403-409.
27. Staff memo to Ron Wyden, Chairman of the Subcommittee on Regulation, Business Opportunities and Technology of the 103rd Congress. Human guinea pigs in the hospital emergency room - how some drug and device manufacturers use patients who can't say no. Mar 11, 1994.
28. Iserson KV, Lindsey D. Research on critically ill and injured patients: rules, reality, and ethics. J Emerg Med 1995; 13:563-567.
29. Biros MH. Development of the multiorganizational document regarding emergency research consent. Acad Emerg Med 1996; 3:101-105.
30. Biros MH, Lewis RJ, Olson CM, et al. Informed consent in emergency research: consensus statement from the Coalition Conference of Acute Resuscitation and Critical Care Researchers. JAMA 1995; 273:1283-1287.
31. Food and Drug Administration and National Institutes of Heath. Executive Summary of the Public Forum on Informed Consent in Clinical Research Conducted in Emergency Circumstances. Bethesda, MD, May 1995.
32. Protection of Human Subjects; Informed Consent and Waiver of Informed Consent Requirements in Certain Emergency Research: Final rules (21 CFR Part 50.24 and 45 CFR Part 46.101
33. Adams JG, Wegener J. "Acting without asking": an ethical analysis of the Food and Drug Administration waiver of informed consent for emergency research. Ann Emerg Med 1999; 33:218-223.
34. Brody BA, Katz J, Dula A. In case of emergency: no need for consent. Hastings Cent Rep 1997; 27(1): 7-12.
35. McRae AD, Weijer C. Lessons from everyday lives: a moral justification for acute care research. Crit Care Med 2002; 30:1146-1151.
36. Ellenberg SS. Informed consent: protection or obstacle? Some emerging issues. Control Clin Trials 1997; 18(6):628-636.
37. Biros MH, Fish SS, Lewis RJ. Implementing the Food and Drug Administration's final rule for waiver of informed consent in certain emergency research circumstances. Acad Emerg Med 1999; 6:1272-1282.
38. Fish SS. Research ethics in emergency medicine. Emerg Med Clin North Am 1999; 17(2):461-474, xii.
39. Lewis RJ. Emergency medicine's "illusion of efficacy" and the public perception of resuscitation research. Acad Emerg Med 1999; 6(8):771-772.
40. Katz J. Blurring the lines: research, therapy and IRBs. Hastings Cent Rep 1997; 27:9-11.
41. Prentice ED. Informed consent: the most important protector. Acad Emerg Med 1999; 6:774-775.
42. Thewes J, FitzGerald D, Sulmasy DP. Informed consent in emergency medicine: ethics under fire. Emerg Med Clin North Am 1996; 14(1):245-254.
43. Dula A. Bearing the brunt of the new regulations: minority populations. Hastings Cent Rep 1997; 27:11-12.
44. Kowey P, Ornato J. Resuscitation research and emergency waiver of informed consent. Resuscitation 2000; 47(3):307-310.
45. Fish SS. Implementing the final rule. Acad Emerg Med 1999; 6:1188-1189.
46. Karlawish JH, Sachs GA. Research on the cognitively impaired: lessons and warnings from the emergency research debate. J Am Geriatr Soc 1997; 45(4):474-481.
47. Ault A. FDA may "pull the plug" on consent waiver, Lancet 1997; 350(9084):1084.
48. Kremers MS, Whisnant DR, Lowder LS, Gregg L. Initial experience using the Food and Drug administration guidelines for emergency research without consent. Ann Emerg Med 1999; 33:224-229.
49. McClure KB, Delorio NM, Gunnels M, et al. Attitudes of ED patients and visitors regarding emergency exception from informed consent in resuscitation research, community consultation and public notification. Acad Emerg Med 2003; 10:352-359.
50. Ragin DF, Holohan JA, Ricci EM, et al. Shocking a community into action: a social marketing approach to cardiac arrests. Journal of Health and Social Policy, Vol. 20, Issue 2.
51. U.S. Department of Health and Human Services Food and Drug Administration. Guidance for Institutional Review Boards, Clinical Investigators and Sponsors: Exception from Informed Consent for Emergency Research. Federal Register. Mar 30, 2000.
52. Baren JM, Anicetti JP, Ledesma S, et al. An approach to community consultation prior to initiating an emergency research study incorporating a waiver of informed consent. Acad Emerg Med 1999; 6:1210-1215.
53. Sloan EP, Nagy K, Barrett J. A proposed consent process in studies that use an exception to informed consent [abstract]. Acad Emerg Med 1999; 6:1283.
54. Davis AM. Exception from informed consent for emergency research: drawing on existing skills and experience. IRB 1998; 20:1-8.
55. Santora TA, Cowell V, Trooskin SZ. Working through the public disclosure process mandated by use of 21 CFR 50.24 (exception to informed consent): guidelines for success. J Trauma 1998; 45:907-913.
56. Shah AN, Sugarman J. Protecting human subjects under the waiver of informed consent for emergency research: experiences with efforts to inform the community. Ann Emerg Med 2003; 41: 72-78.
57. Lewis RJ, Berry DA, Cryer H 3rd. Monitoring a clinical trial conducted under the Food and Drug Administration regulations allowing a waiver of prospective informed consent: the Diaspirin cross-linked hemoglobin traumatic hemorrhagic shock efficacy trial. Ann Emerg Med 2001; 38:397-404.
58. Erb T, Sugarman J. Ethical issues on informed consent and recruitment for clinical trials. Anesthesiology 2000; 92(6):1851-1852.
59. Marwick C. Assessment of exception to informed consent. JAMA 1997; 278:1392-1393.
60. Clifton GL, Knudson P, McDonald M. Waiver of consent in studies of acute brain injury. J Neuro Trauma 2002; 19:1121-1126.
61. Biros MH. Research without consent: current status, 2003. Ann Emerg Med 2003; 42(4):550-564.
62. Hallstrom AP, Ornato JP, Weisfeldt M, et al.; Public Access Defibrillation Trial Investigators. Public-access defibrillation and survival after out-of-hospital cardiac arrest. N Engl J Med 2004; 351(7):637-646.
63. Mosesso VN Jr, Brown LH, Greene HL, et al. Conducting research using the emergency exception from informed consent: the Public Access Defibrillation (PAD) Trial experience. Resuscitation 2004: 61(1):29-36.
64. Silverman H, Hull SC, Sugarman J. Variability among institutional review boards' decisions within the context of a multicenter trial. Crit Care Med 2001; 29:235-241.
65. Smithline HA, Gerstle ML. Waiver of informed consent: a survey of emergency medicine patients. Am J Emerg Med 1997; 16:90-91.
66. The Community VOICES Study (aka Community Views On Informed Consent in Emergency Situations) is funded through National Heart lung and Blood Institute Grant 5R01HL073387-02
67. Richardson, LD, P.I. "Research Without Consent: The Community Perspective." http://crisp.cit.nih.gov/crisp/crisp_query.generate_screen (accessed 1/19/05).